Phenoxodiol in Treating Patients With Refractory Solid Tumors
NCT00022295
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
idronoxil
Sponsor
Kazia Therapeutics Limited